 |
Martin Gerstel | |
|---|---|
 | |
| Born | June 26, 1941 |
| Nationality | Israeli |
| Alma mater | Yale University, Stanford Graduate School of Business |
| Occupation | Businessman |
Martin Gerstel (born June 26, 1941) is an Israeli businessman. He was the CEO and co-chairman of Alza Corp. [1] Martin Gerstel founded ALZA Corp. and Itamar Medical Ltd. M
Gerstel attended Yale University from which he received his undergraduate degree. [2] He went on to receive an MBA from Stanford Graduate School of Business.
Gerstel held the position of Co-CEO of Compugen Ltd. and chairman for Keddem Bioscience Ltd. He founded ALZA Corp at which he was a chief executive and financial officer. [3] [4] He is the chairman of Compugen (Israeli company), Evogene, Keddem Bioscience, Mada Ltd.
Gerstel is the co-founder and co-chairman of Itamar Medical, and serves as a director of Yissum Research Development Company of Hebrew University Ltd., Yeda Ltd. and the Foundation for the U.S. National Medals of Science and Technology.
Gerstel is a member of the Board of Governors and the Executive Committee of the Weizmann Institute of Science and the Board of Governors of The Hebrew University of Jerusalem. He is an advisor to the Burrill Life Science Funds and the board of the Israel-U.S. Binational Industrial Research and Development Foundation ("BIRD"). [5]
As of 2019 Gerstel is the CFO and a director of a cybersecurity company preventing DDoS attacks, MazeBolt Technologies Ltd.
ImClone Systems Incorporated was a biopharmaceutical company dedicated to developing biologic medicines in the area of oncology. It was founded in 1984 and had its corporate headquarters in Bridgewater, New Jersey, and its research headquarters in New York City. On October 6, 2008, it accepted a $6.5 billion acquisition offer from Eli Lilly and Company, and became a fully-owned subsidiary of Eli Lilly and Company on November 24, 2008. Prior to the acquisition, it was traded on the NASDAQ stock exchange under the symbol IMCL. Imclone lost its separate identity in 2014 when its former ImClone research and manufacturing sites were renamed Eli Lilly and Company.
The Hebrew University of Jerusalem is a public research university based in Jerusalem, Israel. Co-founded by Albert Einstein and Chaim Weizmann in July 1918, the public university officially opened in April 1925. It is the second-oldest Israeli university, having been founded 30 years before the establishment of the State of Israel but six years after the older Technion university. The HUJI has three campuses in Jerusalem and one in Rehovot. Until 2023, the world's largest library for Jewish studies—the National Library of Israel—was located on its Edmond J. Safra campus in the Givat Ram neighbourhood of Jerusalem.
Israel Harold "Izzy" Asper was a Canadian tax lawyer and media magnate. He was the founder and owner of the now-defunct TV and media company CanWest Global Communications Corp and father to its former CEO and President Leonard Asper, former director and corporate secretary Gail Asper, as well as former Executive Vice President David Asper. He was also the leader of the Manitoba Liberal Party from 1970 to 1975 and is credited with the idea and vision to establish the Canadian Museum for Human Rights.
Alza Corporation was an American pharmaceutical and medical systems company.
Aaron Ciechanover is an Israeli biologist who won the Nobel Prize in Chemistry for characterizing the method that cells use to degrade and recycle proteins using ubiquitin.
Joseph "Yossi" Vardi is an Israeli entrepreneur and investor. He is one of Israel's first high-tech entrepreneurs, one of the pioneers of the Israeli internet industry. For over 47 years, he has founded and helped to build over 85 high-tech companies in a variety of fields, among them software, energy, Internet, mobile, electro-optics and water technology.
Sigma-Aldrich is an American chemical, life science, and biotechnology company owned by the multinational chemical conglomerate Merck Group.
Gil Shwed is an Israeli software engineer and entrepreneur. He is the co-founder and CEO of Check Point Software Technologies Ltd, one of Israel's largest technology companies and the world's largest pure-play cybersecurity company.
Itamar Rabinovich is the president of the Israel Institute. He was Israel's Ambassador to the United States in the 1990s and former chief negotiator with Syria between 1993 and 1996, and the former president of Tel Aviv University (1999–2007). Currently he is professor emeritus of Middle Eastern History at Tel Aviv University, distinguished global professor at New York University and a distinguished fellow at the Brookings Institution.
Aluf Eitan Ben Eliyahu is a retired major general in the Israel Defense Forces and was the Commander of the Israeli Air Force (IAF).
Eliyahu "Eli" Hurvitz was an Israeli industrialist. He was the chairman of the board and former CEO of Teva Pharmaceutical Industries at the time of his death.
Haim Aviv was an Israeli scientist who specialized in the field of molecular biology. Aviv is considered to have a fundamental role in the shaping of the biotechnology industry in Israel, as he was widely involved in this industry since the late 1970s to this day.
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange.
CompugenLtd. is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993. Compugen originally acted as service provider for pharma companies, supplying its software and computational services to predict different types of biological phenomena. It had arrangements with big companies such as Novartis AG, Abbot Laboratories and Pfizer Inc. Subsequently, Compugen made a decision to become a drug development company with its own internal pipeline, and in 2010, decided to a focus on oncology and immunology. OncoMed Pharmaceuticals and Five Prime Therapeutics are among Compugen's competitors.
Yair Shamir is an Israeli politician, businessman and former military officer. He served as a member of the Knesset for Yisrael Beiteinu between 2013 and 2015, during which he also held the post of Minister of Agriculture.
Yaakov Hagoel, is the Chairman of the Executive of the World Zionist Organization. He was formerly acting chairman of The Jewish Agency for Israel.
Michael Ilan Yoel "Mikey" Federmann is an Israeli drone manufacturer and billionaire. He is in charge of Elbit Systems and the Dan Hotels group. Under his leadership Elbit Systems multiplied its size many times and became a major player in the Unmanned Aerial Vehicle market globally as well as in other areas of military defence technology.
Aaron G. Frenkel is an international entrepreneur, investor and philanthropist.
Avner Halperin is an Israeli entrepreneur and CEO of Sheba Impact - the entrepreneurship and innovation company of Sheba Medical Center. He is also EyeControl's Chairman of the Board of Directors, a Research Fellow at Harvard Kennedy School, and an adjunct professor at Tel Aviv University.
Michel Bercovier is a French-Israeli Professor (Emeritus) of Scientific Computing and Computer Aided Design (CAD) in The Rachel and Selim Benin School of Computer Science and Engineering at the Hebrew University of Jerusalem. Bercovier is also the head of the School of Computer Science at the Hadassah Academic College, Jerusalem.